Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Royal Pharmaceutical Society

Apr 30, 2026 9:00 AM - Apr 30, 2026 5:00 PM

66 East Smithfield, London, E1W 1AW, United Kingdom

UK National QPPV Workshop

Early-Bird rate for DIA Industry Members Available!

DAYS

HOURS

MINUTES

SECONDS

Overview

Join us at the UK National QPPV Forum - Celebrating the 5th Edition, In-Person

Adapting to Change: Navigating New Regulatory Requirements in the UK

The UK regulatory landscape continues to evolve rapidly, with new legislation and frameworks shaping pharmacovigilance and clinical operations. This year’s UK National QPPV Workshop will provide practical insights and updates on the latest developments impacting QPPVs and PV professionals across the UK.

Join regulators, industry experts, and your peers to discuss how to navigate recent and upcoming changes - including the implementation of the UK Clinical Trials Regulation, updates on MHRA inspection trends, and the latest device post-marketing requirements.

You’ll also gain perspectives on RMP effectiveness assessments, digitalisation of educational materials, and data protection obligations within the UK framework.

This annual workshop remains a trusted platform for QPPVs to share experiences, learn from MHRA representatives, and collaborate on solutions for real-world compliance and operational excellence in the UK market.

Featured topics

Through interactive sessions and open discussions, participants will:

  • Hear quick regulatory updates directly addressing audience questions and recent survey topics.
  • Discuss practical implementation of safety variations, ICSR submissions, and post-marketing surveillance.
  • Explore challenges and best practices around risk minimisation measures and data protection.
  • Exchange experiences on inspection trends and blue-sky thinking for innovation in pharmacovigilance.

Who should attend?

  • UK or EU QPPVs
  • UK NCPs
  • Deputy QPPVs
  • Regulators
  • Pharmacovigilance Consultants
  • Directors of Pharmacovigilance Oversight and Standards
  • Drug Safety Managers/Leaders
  • Auditors

 

Program Committee

  • Elspeth  McIntosh, MBA, RN
    Elspeth McIntosh, MBA, RN Director
    Castle Pharmacovigilance Ltd, United Kingdom
  • Sophie  Radicke, MSC
    Sophie Radicke, MSC Head of GPvP and Senior Pharmacovigilance Inspector
    Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
  • Louise  Woodward, PHD
    Louise Woodward, PHD UK QPPV and Local Safety Responsible
    Roche Products Ltd, United Kingdom
  • Helen  Fiddes
    Helen Fiddes Head of Country Pharmacovigilance, UK and Ireland
    Bristol-Myers Squibb, United Kingdom
  • Lauren  East
    Lauren East Head, Pharmacovigilance UK
    Abbvie, United Kingdom
  • Rory  Littlebury
    Rory Littlebury Head of PVSO and QPPV Office
    GlaxoSmithKline (GSK), United Kingdom

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.